Economic Survey 2023: India administered over 220 crore Covid-19 vaccines
About 97% of eligible beneficiaries have already received at least one dose of Covid-19 vaccine and around 90% have received both the doses.
About 97% of eligible beneficiaries have already received at least one dose of Covid-19 vaccine and around 90% have received both the doses.
Bharat Biotech’s vaccine dubbed as “game changer”; to offer efficient distribution and easy and pain-free administration.
The iNCOVACC vaccine received Indian drug regulator's approval to be used as a booster dose for the adult population.
The jab will be supplied to the government at ₹145, helping the exchequer save ₹1,500 crore.
Civil society groups in several parts of the world have flayed the compromise formula thrashed out by the quadrilateral discussions, terming it as a very limited and narrow agreement.
Resurgence of interest and new technologies bring a huge opportunity for the vaccine development field, says Biocon CMD Kiran Mazumdar-Shaw.
The Omicron wave has not changed matters as studies and clinical evidence shows vaccination offers strong protection against serious disease
Daily positivity rate in India has increased to 14.78% from 13.11% a day ago and weekly positivity rate is now at 11.83%.
India had called for a virtual ministerial meeting to discuss waiver of certain provisions of the TRIPS agreement for Covid-19-related pharmaceuticals.
Maharashtra, which has a total of over two lakh Covid-19 active cases, reported over 29,000 cases in a day.